- Home
- CERO vs REBN Comparison
CERO vs REBN Comparison
Compare CERO & REBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CERO
- REBN
- Stock Information
- Founded
- CERO 2017
- REBN 2015
- Country
- CERO United States
- REBN United States
- Employees
- CERO N/A
- REBN N/A
- Industry
- CERO
- REBN Restaurants
- Sector
- CERO
- REBN Consumer Discretionary
- Exchange
- CERO Nasdaq
- REBN Nasdaq
- Market Cap
- CERO 3.5M
- REBN 12.8M
- IPO Year
- CERO N/A
- REBN 2022
- Fundamental
- Price
- CERO $8.90
- REBN $2.75
- Analyst Decision
- CERO Strong Buy
- REBN
- Analyst Count
- CERO 2
- REBN 0
- Target Price
- CERO $45.00
- REBN N/A
- AVG Volume (30 Days)
- CERO 3.3M
- REBN 60.7K
- Earning Date
- CERO 08-13-2025
- REBN 08-18-2025
- Dividend Yield
- CERO N/A
- REBN N/A
- EPS Growth
- CERO N/A
- REBN N/A
- EPS
- CERO N/A
- REBN N/A
- Revenue
- CERO N/A
- REBN $6,103,732.00
- Revenue This Year
- CERO N/A
- REBN $335.98
- Revenue Next Year
- CERO N/A
- REBN N/A
- P/E Ratio
- CERO N/A
- REBN N/A
- Revenue Growth
- CERO N/A
- REBN 3.38
- 52 Week Low
- CERO $6.71
- REBN $1.03
- 52 Week High
- CERO $895.40
- REBN $8.30
- Technical
- Relative Strength Index (RSI)
- CERO 46.23
- REBN 57.62
- Support Level
- CERO $8.50
- REBN $2.61
- Resistance Level
- CERO $9.73
- REBN $3.16
- Average True Range (ATR)
- CERO 1.20
- REBN 0.20
- MACD
- CERO -0.01
- REBN 0.06
- Stochastic Oscillator
- CERO 14.54
- REBN 68.46
About CERO CERo Therapeutics Holdings Inc. Common Stock
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy. Its lead molecule is CER-1236, an autologous T-cell product that targets a novel tumor antigen, TIM-4 ligand.
About REBN Reborn Coffee Inc.
Reborn Coffee Inc is an operator and franchisor of retail locations and kiosks that focus on serving specialty-roasted coffee. It is an company that strives for constant improvement in the coffee experience through exploration of new technology and premier service, guided by traditional brewing techniques. The company operates in one reportable segment, consisting of both the wholesale and retail sales of coffee, water, and other beverages.